European Archives - Page 663 of 1002 - European Medical Journal

Predicting the Impact of Health Interventions

Predicting the full impact of health interventions and planning services could become easier following the development of a new framework designed…

ESHRE 2018 - Interview - Dean Morbeck

An interview with Dean Morbeck (Scientific Director, Fertility Associates, Auckland, New Zealand) at this year’s ESHRE Congress held in Barcelona, Spain.

ESHRE 2018 - Interview - Dr Elena Labarta

An interview with Dr Elena Labarta (Gynaecologist, IVI Clinic Valencia, Valencia, Spain) at this year’s ESHRE Congress held in Barcelona, Spain.

Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…

EMJ Gastroenterology 7 [Suppl 2] 2018

This symposium took place on 16th February 2018 as part of the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Vienna, Austria

Individualised Care for Crohn's Disease: Evolving Approaches for a Progressive Disease

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.

Routine Lung Check Enables Early Detection of Lung Cancer

A project in which people deemed to be at risk of poor lung health are invited to attend a routine lung health check has been highly…

Association Between Skin Cancer and the Risk of Other Malignancies

Basal cell carcinoma is one of the most common forms of skin cancer, with millions of Americans diagnosed with the malignancy each year. However…

Low Oxygen Concentration and Thrombosis

Hypoxia is commonly found in a number of disorders, including cancers, alcoholism, sickle cell anaemia, and nonalcoholic fatty liver disease. The oxygen…

New Scale Helps Match Patients to the Optimal Cancer Therapy

Targeted cancer treatment options should become more simplified and standardised following the creation of a new scale for tumour DNA mutations that has…